FDA inspection
Carter BloodCare - Baylor: FDA inspection ending Apr 26, 2024
FDA inspection 1237401 · No Action Indicated (NAI) · Dallas, TX
Key facts
| Inspection ID | 1237401 |
|---|---|
| Firm | Carter BloodCare - Baylor |
| FEI number | 1674451 |
| Address | 4201 Gaston Ave Ste 110 |
| City | Dallas |
| State | TX |
| ZIP | 75246 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Apr 26, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data